Total Funding
51
42
Total FundingSeries D raised
Growth Score 51 in past quarter
-1 pts
Heat Score 42 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
62236
uBriGene is driven by the advancement of gene and cell therapy technologies through research and development.
- Qichen Li: Co-Founder and President
- Xiulian Sun: Chairman and Chief Scientist
About the Company
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.